Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

Jan 26, 2024 Nat Commun

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

Panda S, Morgan J, Cheng C, Saito M, Gilman RH, Ciobanu N, Crudu V, Catanzaro DG, Catanzaro A, Rodwell T, Perera JSB, Chathuranga T, Gunasena B, DeSilva AD, Peters B, Sette A, Lindestam Arlehamn CS

Nov 1, 2023 Curr Protoc

The megapool approach to characterize adaptive CD4+ and CD8+ T cell responses

da Silva Antunes R, Weiskopf D, Sidney J, Rubiro P, Peters B, Lindestam Arlehamn CS, Grifoni A, Sette A

Feb 13, 2024 Front Oncol

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

Vita S, D'Abramo A, Coppola A, Farroni C, Iori AP, Faraglia F, Sette A, Grifoni A, Lindestam Arlehamn C, Bibas M, Goletti D, Nicastri E

Feb 12, 2024 bioRxiv

PINK1 is a target of T cell responses in Parkinson’s disease

Williams GP, Michaelis T, Lima-Junior JR, Frazier A, Tran NK, Phillips EJ, Mallal SA, Litvan I, Goldman JG, Alcalay RN, Sidney J, Sulzer D, Sette A, Lindestam Arlehamn CS

Feb 6, 2024 Research News

How T cells combat tuberculosis

By tracking T cell activity, researchers uncover promising tuberculosis vaccine and drug targets

Jan 7, 2023 bioRxiv

M. tuberculosis antigen-responsive IL17 + CD4 T cells are disproportionately spared in ART-suppressed HIV

Ogongo P, Tran A, Marzan F, Gingrich D, Krone M, Aweeka F, Lindestam Arlehamn CS, Martin JN, Deeks SG, Hunt PW, Ernst JD

Jan 15, 2023 J Neurol Sci

Unaltered T cell responses to common antigens in individuals with Parkinson’s disease

Williams GP, Muskat K, Frazier A, Xu Y, Mateus J, Grifoni A, da Silva Antunes R, Weiskopf D, Amara AW, Standaert DG, Goldman JG, Litvan I, Alcalay RN, Sulzer D, Lindestam Arlehamn CS, Sette A

Feb 6, 2023 Front Immunol

Corrigendum: Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosis-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis

Du Bruyn E, Ruzive S, Howlett P, Cerrone M, Jacobs AJ, Lindestam Arlehamn CS, Sette A, Sher A, Mayer-Barber KD, Barber DL, Mayosi B, Ntsekhe M, Wilkinson RJ, Riou C

Apr 14, 2023 Front Immunol

Lindestam Arlehamn

Identification of differentially recognized T cell epitopes in the spectrum of tuberculosis infection

The megapool approach to characterize adaptive CD4+ and CD8+ T cell responses

Combined antiviral therapy as effective and feasible option in allogenic hematopoietic stem cell transplantation during SARS-COV-2 infection: a case report

PINK1 is a target of T cell responses in Parkinson’s disease

How T cells combat tuberculosis

M. tuberculosis antigen-responsive IL17 + CD4 T cells are disproportionately spared in ART-suppressed HIV

Unaltered T cell responses to common antigens in individuals with Parkinson’s disease

Corrigendum: Comparison of the frequency and phenotypic profile of Mycobacterium tuberculosis-specific CD4 T cells between the site of disease and blood in pericardial tuberculosis

Antigen-specificity measurements are the key to understanding T cell responses

Identification of differentially recognized T cell epitopes in the spectrum of Mtb infection

A protective, single-visit TB vaccination regimen by co-administration of a subunit vaccine with BCG

Host genetic background is a barrier to broadly effective vaccine-mediated protection against tuberculosis